TG Therapeutics Inc (TGTX)
34.50
+3.36
(+10.77%)
USD |
NASDAQ |
Nov 21, 16:00
34.60
+0.10
(+0.28%)
After-Hours: 20:00
TG Therapeutics Enterprise Value: 4.752B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.752B |
| November 19, 2024 | 4.623B |
| November 18, 2024 | 4.512B |
| November 15, 2024 | 4.501B |
| November 14, 2024 | 4.705B |
| November 13, 2024 | 5.336B |
| November 12, 2024 | 4.715B |
| November 11, 2024 | 4.688B |
| November 08, 2024 | 4.388B |
| November 07, 2024 | 4.246B |
| November 06, 2024 | 4.133B |
| November 05, 2024 | 3.929B |
| November 04, 2024 | 3.695B |
| November 01, 2024 | 4.094B |
| October 31, 2024 | 3.807B |
| October 30, 2024 | 3.818B |
| October 29, 2024 | 3.908B |
| October 28, 2024 | 3.696B |
| October 25, 2024 | 3.542B |
| October 24, 2024 | 3.520B |
| October 23, 2024 | 3.506B |
| October 22, 2024 | 3.681B |
| October 21, 2024 | 3.699B |
| October 18, 2024 | 3.534B |
| October 17, 2024 | 3.632B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.720B |
| October 15, 2024 | 3.731B |
| October 14, 2024 | 3.460B |
| October 11, 2024 | 3.358B |
| October 10, 2024 | 3.304B |
| October 09, 2024 | 3.314B |
| October 08, 2024 | 3.305B |
| October 07, 2024 | 3.223B |
| October 04, 2024 | 3.366B |
| October 03, 2024 | 3.360B |
| October 02, 2024 | 3.389B |
| October 01, 2024 | 3.460B |
| September 30, 2024 | 3.547B |
| September 27, 2024 | 3.575B |
| September 26, 2024 | 3.497B |
| September 25, 2024 | 3.500B |
| September 24, 2024 | 3.494B |
| September 23, 2024 | 3.485B |
| September 20, 2024 | 3.702B |
| September 19, 2024 | 3.799B |
| September 18, 2024 | 3.795B |
| September 17, 2024 | 3.768B |
| September 16, 2024 | 3.739B |
| September 13, 2024 | 3.559B |
| September 12, 2024 | 3.476B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
374.24M
Minimum
Jun 16 2022
7.393B
Maximum
Dec 21 2020
2.638B
Average
2.359B
Median
Enterprise Value Benchmarks
| ADMA Biologics Inc | 5.066B |
| Varex Imaging Corp | 890.76M |
| Rhythm Pharmaceuticals Inc | 3.350B |
| Inspire Medical Systems Inc | 5.126B |
| Mirum Pharmaceuticals Inc | 2.121B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.88M |
| Revenue (Quarterly) | 83.88M |
| Total Expenses (Quarterly) | 71.44M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 88.86% |
| Profit Margin (Quarterly) | 4.63% |
| Earnings Yield | -0.32% |
| Normalized Earnings Yield | -0.3188 |